Stocks
Avadel Pharmaceuticals PLCAVDL
NASDAQHealthcareBiotechnology$21.64
A biopharmaceutical company focused on developing and commercializing treatments for sleep disorders, particularly narcolepsy. Its lead product, Lumryz, is an extended‑release sodium oxybate approved in the U.S. for treating excessive daytime sleepiness and cataplexy in narcolepsy patients. Investor...
52W Range: $6.38 – $23.57
Congressional Interest in Avadel Pharmaceuticals PLC (AVDL)
No congressional trades have been disclosed for Avadel Pharmaceuticals PLC (AVDL) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading AVDL?
No congressional trades found for this stock.